abbreviation
- Ann. Rheum. Dis.
Annals of the Rheumatic Diseases
Journal
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication venue for
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: Results from a randomised, placebo-controlled trial. 79:1340-1348. 2020-01-01
- Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: Results of a multicentre, double-blind, randomised-withdrawal trial. 77:21-29. 2018-01-01
- Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study. 76:355-363. 2017-01-01
- Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study. 76:346-354. 2017-01-01
- Abatacept in subjects who switch from intravenous to subcutaneous therapy: Results from the phase IIIb ATTUNE study. 71:857-861. 2012-01-01
- Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-Year results from the AIM trial. 70:1826-1830. 2011-01-01
- Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). 69:1629-1635. 2010-01-01
- Correspondence on € Tapering towards DMARD-free remission in rheumatoid arthritis' 2020-01-01
- Statins in systemic lupus erythematosus 2018-01-01
- Are steroids required for induction therapy and relapses in lupus nephritis? 2013-01-01
- Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agents [4] 2007-01-01